“Bullish on Aurobindo Pharma, recommending a buy with a target price of ₹1,820 and a stop loss of ₹1,665. The stock is in an overall uptrend, trading in all-time high territory, reflecting strong bullish momentum. It has surpassed its previous swing high near ₹1,680, forming higher highs, and the RSI shows a bullish crossover.”

Chandan Taparia’s track record: 3 graded calls · 95% CI 0–56%